Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
This article compares withdrawal strategies using multi-asset portfolios versus the SP 500, highlighting risk, diversification, and potential retirement outcomes.
23,797 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
NuScale Power has sparked excitement around small modular reactors, but does the hype translate into real investing u...
Joby Aviation stock trades near multi-month lows as investors weigh FAA milestones, manufacturing scale, and internat...
As refined product margins surge, a veteran energy analyst says the bottleneck is refining capacity, not crude supply...
SK Hynix moves to list in the U.S., challenging Micron for memory-chip dominance as AI-driven demand and cyclical dyn...
SpaceX held firm through a choppy month, outperforming peers in the space stock group. The market’s rotation favored ...
Alphabet reports higher capital investment as it bets on AI and cloud, challenging the resilience of its trillion-dol...
IBM slumped 22% in early trading on a preliminary Q2 miss, igniting a wider tech sector selloff as analysts weigh AI ...
Analysts publish an eyebrow-raising spacex’s $800 price target, implying a potential trillion-dollar leap in value an...
Meta Platforms appears poised for a potential move toward $700 as earnings beat and AI-driven monetization clash with...
June's jet deliveries offer a clear signal about Boeing's momentum as it nears the July earnings report. This article...
As AI investment accelerates, the capex question every holder for QQQ becomes central. The article examines how AI-dr...